Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna original article Wien Klin Wochenschr (2017) 129:517–526 DOI 10.1007/s00508-016-1162-y Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna Sebastian Steiner · Theresa Bucsics · Philipp Schwabl · Mattias Mandorfer · Bernhard Scheiner · Maximilian Christopher Aichelburg · Katharina Grabmeier-Pfistershammer · Peter Ferenci · Michael Trauner · Markus Peck-Radosavljevic · Thomas Reiberger Received: 18 August 2016 / Accepted: 19 December 2016 / Published online: 27 January 2017 © The Author(s) 2017. This article is available at SpringerLink with Open Access. Summary of SOF/LDV and 60% of 2D/3D patients prior to Aim We aimed to investigate the efficacy of interferon anti-HCV treatment due to expected DDIs. We ob- and ribavirin-free sofosbuvir/ledipasvir (SOF/LDV) served sustained virologic response (SVR) rates of and ritonavir boosted paritaprevir/ombitasvir with 100% in patients treated with SOF/LDV (19/19) and or without dasabuvir (2D/3D) regimens in a real-life 2D/3D (14/14). One 2D/3D patient was lost to follow- cohort of human immunodeficiency virus/hepatitis up, while two SOF/LDV patients died during ther- C virus (HIV/HCV) coinfected patients. The study apy from non-treatment-related causes. They were focused on efficacy, need for changes in antiretroviral excluded from the analysis. Between baseline and fol- therapy (ART) due to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Wiener klinische Wochenschrift Springer Journals

Loading next page...
 
/lp/springer_journal/progress-in-eradication-of-hcv-in-hiv-positive-patients-with-3xBc6efYbZ
Publisher
Springer Vienna
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Medicine/Public Health, general; Internal Medicine; Endocrinology; Gastroenterology; Pneumology/Respiratory System
ISSN
0043-5325
eISSN
1613-7671
D.O.I.
10.1007/s00508-016-1162-y
Publisher site
See Article on Publisher Site

Abstract

original article Wien Klin Wochenschr (2017) 129:517–526 DOI 10.1007/s00508-016-1162-y Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna Sebastian Steiner · Theresa Bucsics · Philipp Schwabl · Mattias Mandorfer · Bernhard Scheiner · Maximilian Christopher Aichelburg · Katharina Grabmeier-Pfistershammer · Peter Ferenci · Michael Trauner · Markus Peck-Radosavljevic · Thomas Reiberger Received: 18 August 2016 / Accepted: 19 December 2016 / Published online: 27 January 2017 © The Author(s) 2017. This article is available at SpringerLink with Open Access. Summary of SOF/LDV and 60% of 2D/3D patients prior to Aim We aimed to investigate the efficacy of interferon anti-HCV treatment due to expected DDIs. We ob- and ribavirin-free sofosbuvir/ledipasvir (SOF/LDV) served sustained virologic response (SVR) rates of and ritonavir boosted paritaprevir/ombitasvir with 100% in patients treated with SOF/LDV (19/19) and or without dasabuvir (2D/3D) regimens in a real-life 2D/3D (14/14). One 2D/3D patient was lost to follow- cohort of human immunodeficiency virus/hepatitis up, while two SOF/LDV patients died during ther- C virus (HIV/HCV) coinfected patients. The study apy from non-treatment-related causes. They were focused on efficacy, need for changes in antiretroviral excluded from the analysis. Between baseline and fol- therapy (ART) due to

Journal

Wiener klinische WochenschriftSpringer Journals

Published: Jan 27, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off